FIRE1

About FIRE1

NORM, developed by FIRE1, aims to revolutionize heart failure management by helping patients regain their normal life. It focuses on restoring independence and maintaining a connection with medical teams through innovative monitoring solutions.

Products & Services

NORM (FIRE1 System):A revolutionary medical device for heart failure patients that allows daily heart monitoring from home. It involves a same-day implant, wearing a belt for a few minutes daily, and using a phone to track heart status. It also keeps doctors connected by sharing daily readings and alerts for potential issues. Note: It is an investigational device and not currently approved for clinical use.

Specialties

Heart Failure Management Medical Device Innovation Remote Health Monitoring

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Financing Round T: - FT: Financing Round	A: 120000000 MR: - FA: $120 million FAN: 120000000	D: 2025-01-07 FD: 2025-01-07	13 investors
2	RT: Financing Round T: - FT: Financing Round	A: 25000000 MR: - FA: 25 million FAN: 25000000	D: 2023-03-15 FD: 2023-03-15	9 investors

Financing Round Latest

2025-01-07

$120.0M

13 investors (Pro only)

Financing Round 2023-03-15

$25.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

FIRE1 Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised